{"id":"W3031418164","doi":"10.1200/jco.2020.38.15_suppl.8510","title":"Selinexor, daratumumab, and dexamethasone in patients with relapsed/refractory multiple myeloma (MM).","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; McGill University Health Centre; Vancouver General Hospital; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Dalhousie University","funders":"Karyopharm Therapeutics","keywords":"Tolerability; Medicine; Daratumumab; Internal medicine; Dexamethasone; Refractory (planetary science); Phases of clinical research; Oncology; Gastroenterology; Adverse effect; Pharmacology; Lenalidomide; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001140623,0.0006373142,0.001232348,0.0003847783,0.0002956991,0.0005629414,0.0003864616,0.0005644275,0.002593181],"category_scores_gemma":[0.000640252,0.0003605282,0.0008392283,0.0003761199,0.0003251716,0.0005546364,0.0003266714,0.0014338,0.0006257494],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006078224,"about_ca_system_score_gemma":0.0008469929,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005710582,"about_ca_topic_score_gemma":0.002753683,"domain_scores_codex":[0.99965,0.0001368063,0.00002990727,0.000062655,0.00004884819,0.000071762],"domain_scores_gemma":[0.9996106,0.00006388757,0.0000808554,0.00001590336,0.00001997662,0.0002086747],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5233346,0.03601658,0.09375098,0.001661711,0.002106741,0.001205417,0.0006421406,0.002464017,0.03722107,0.0002764202,0.006630322,0.29469],"study_design_scores_gemma":[0.193848,0.6214123,0.159528,0.0001469179,0.001479852,0.001783559,0.000245697,0.00221839,0.004628221,0.0002183838,0.01443888,0.00005190677],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913585,0.005273105,0.0001198815,0.000426446,0.00009103221,0.0005552244,0.0004151046,0.00003981494,0.001720873],"genre_scores_gemma":[0.9949386,0.001753915,0.000456249,0.0004952954,0.0001128864,0.0003197063,0.0005496579,0.000006023115,0.001367701],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002593181,"threshold_uncertainty_score":0.008675098,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06782082982133822,"score_gpt":0.3764753852132049,"score_spread":0.3086545553918667,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}